ATI-1777

Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Clinical Trials Arena
Wed, 10/4/23 - 11:10 am
Aclaris
ATI-1777
atopic dermatitis
JAK inhibitors